Beta decay in science and medicine

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 4, 2007, Pages 437-439

  Welsh, James S ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Riverview Hospital Association   (United States)

^c UW Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CESIUM 137; COBALT 60; FLUORINE 18; GOLD 198; IBRITUMOMAB TIUXETAN; IODINE 131; IRIDIUM 192; LEXIDRONAM SAMARIUM SM 153; PHOSPHORUS 32; POTASSIUM 40; RADIOPHARMACEUTICAL AGENT; SAMARIUM 153; STRONTIUM 89; STRONTIUM 90; TOSITUMOMAB I 131; YTTRIUM 90;

BETA RADIATION; BONE METASTASIS; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER THERAPY; DRUG HALF LIFE; FOLLOW UP; GAMMA RADIATION; HUMAN; MEDICINE; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; RADIOIMMUNOTHERAPY; RADIOISOTOPE DECAY; REVIEW; SCIENCE; TELETHERAPY;

BETA RAYS; HUMANS; MEDICAL ONCOLOGY; RADIOPHARMACEUTICALS;

EID: 34548384378     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000258753.09234.0c     Document Type: Review

References (1)

1. Welsh JS. Electron capture. Am J Clin Oncol. 2006;29:540-542.